Evidence map›Paper›PMID 39267765›Full record

ArticleFrontiers in immunology2024

Radiomics-based machine learning model to phenotype hip involvement in ankylosing spondylitis: a pilot study.

Zhengyuan Hu, Yan Wang, Xiaojian Ji, Bo Xu, Yan Li, Jie Zhang, Xingkang Liu, Kunpeng Li, Jianglin Zhang, Jian Zhu and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhengyuan Hu *Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Yan Wang *Department of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xiaojian Ji *Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Bo XuBasic Research Center for Medical Science, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, China.
Yan LiDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jie ZhangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xingkang LiuDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Kunpeng LiDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jianglin ZhangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jian ZhuDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xin LouDepartment of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Feng HuangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Hip involvement is an important reason of disability in patients with ankylosing spondylitis (AS). Unveiling the potential phenotype of hip involvement in AS remains an unmet need to understand its biological mechanisms and improve clinical decision-making. Radiomics, a promising quantitative image analysis method that had been successfully used to describe the phenotype of a wide variety of diseases, while it was less reported in AS. The objective of this study was to investigate the feasibility of radiomics-based approach to profile hip involvement in AS. Methods: A total of 167 patients with AS was included. Radiomic features were extracted from pelvis MRI after image preprocessing and feature engineering. Then, we performed unsupervised machine learning method to derive radiomics-based phenotypes. The validation and interpretation of derived phenotypes were conducted from the perspectives of clinical backgrounds and MRI characteristics. The association between derived phenotypes and radiographic outcomes was evaluated by multivariable analysis. Results: 1321 robust radiomic features were extracted and four biologically distinct phenotypes were derived. According to patient clinical backgrounds, phenotype I (38, 22.8%) and II (34, 20.4%) were labelled as high-risk while phenotype III (24, 14.4%) and IV (71, 42.5%) were at low risk for hip involvement. Consistently, the high-risk phenotypes were associated with higher prevalence of MRI-detected lesion than the low-risk. Moreover, phenotype I had significant acute inflammation signs than phenotype II, while phenotype IV was enthesitis-predominant. Importantly, the derived phenotypes were highly predictive of radiographic outcomes of patients, as the high-risk phenotypes were 3 times more likely to have radiological hip lesion than the low-risk [27 (58.7%) vs 16 (28.6%); adjusted odds ratio (OR) 2.95 (95% CI 1.10, 7.92)]. Conclusion: We confirmed for the first time, the clinical actionability of profiling hip involvement in AS by radiomics method. Four distinct phenotypes of hip involvement in AS were identified and importantly, the high-risk phenotypes could predict structural damage of hip involvement in AS.

Indexed as

Machine LearningMagnetic Resonance ImagingPhenotypeSpondylitis, AnkylosingAdultFemaleHumansMaleMiddle AgedPilot ProjectsRadiomicsankylosinghip involvementmachine learningmagnetic resonance imagingradiomicsspondylitis

Identifiers

PMID39267765
PMCPMC11390496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.